-+ 0.00%
-+ 0.00%
-+ 0.00%
Lineage Cell Therapeutics CFO Jill Ann Howe Acquires $17,100 in Common Shares
Share
Listen to the news
Lineage Cell Therapeutics CFO Jill Ann Howe Acquires $17,100 in Common Shares
  • Lineage Cell Therapeutics Chief Financial Officer Jill Ann Howe purchased 20,000 common shares at $0.855 each.
  • Her direct beneficial ownership rose to 45,500 common shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lineage Cell Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-463787), on November 16, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending